FDA Approved: SUCRALFATE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for sucralfate from Chartwell RX, LLC under an ANDA. The action represents an update to the approved labeling or formula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Peptic Ulcer Disease

Drugs mentioned

• SUCRALFATE (SUCRALFATE)

Snippet

SUPPL AP for SUCRALFATE (SUCRALFATE)